All you need to know about Godhra train burning case

Agencies
October 9, 2017

New Delhi, Oct 9: The Gujarat high court is likely to pronounce its verdict on a set of appeals challenging convictions and acquittals by a Special Investigation Team court in the 2002 Godhra train burning case on Monday, more than two years after the completion of hearings on the matter.

The judgement will be delivered by a bench of justice Anant Dave and justice GR Udhwani at about 11am.

Here’s all you need to know about the case:

Train set on fire

A coach of the Sabarmati Express was set on fire at Godhra on February 27, 2002. The blaze in S6 coach killed 59 Hindus, mostly karsevaks or volunteers returning from Ayodhya, where rival Hindu and Muslim groups are locked in a decades-old dispute over a religious site.

The train fire sparked three days of reprisal attacks across the state that left 790 Muslims and 254 Hindus dead, official sources say. And as many as 100,000 Muslims and 40,000 Hindus were rendered homeless in the riots. About 130 are still reported missing.

Probe into the carnage

The Nanavati Commission, appointed by the Gujarat government to probe the incident, concluded that the fire in the coach was not an accident but it was set on fire. The Sangh Parivar claimed the train fire was targeted at the Hindus, who were returning to Ayodhya after a pilgrimage.

A damning report of Mohinder Singh Dahiya, the then assistant director of Gandhinagar’s Forensic Studies Laboratory (FSL), concluded that the coach was set afire by someone “standing in the passage of the compartment near seat number 72, using a container with a wide opening about 60 litres of inflammable liquid has been poured and then a fire has been started in the bogie”.

The accused

The special SIT court on March 1, 2011, convicted 31 people and acquitted 63 in the case. While 11 people were sentenced to death, 20 were handed out life imprisonment.

The court convicted 31 people while accepting the prosecution’s contention that there was a conspiracy behind the incident.

All the 31 were convicted under various sections of the Indian Penal Code related to murder, attempt to murder and criminal conspiracy. Those acquitted included prime accused Maulana Umarji, the then president of Godhra municipality Mohammad Hussain Kalota, Mohammad Ansari and Nanumiya Chaudhary of Gangapur, Uttar Pradesh.

Later, several appeals were filed in the high court challenging the convictions, while the Gujarat government questioned the acquittal of the 63 people.

The 2002 Gujarat riots

There were SIT probes into the involvement of several political leaders, including Prime Minister Narendra Modi - who was then the Gujarat chief minister - for criminal conspiracy in the riots. Modi and others were cleared after the SIT filed a closure report on February 8, 2012.

Maya Kodnani, the women and child welfare minister in the then Modi government in Gujarat, was sentenced to life in prison for a separate case of rioting in Ahmedabad’s Naroda Patiya area, a verdict she has challenged. She has been on bail since 2014.

Comments

Althaf
 - 
Monday, 9 Oct 2017

When court is controlling by sangh parivar then what verdict we can expect ?? All verdict will be in favor of sangh parivar.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 22,2020

New Delhi, Mar 22: The total number of novel coronavirus cases in India rose to 341 on Sunday after fresh cases were reported from various parts of the country, the Union Health Ministry said.

The total includes 41 foreign nationals and five deaths, the latest being reported from Maharashtra, taking the death toll in the state to two.

Delhi, Karnataka and Punjab have reported one death each so far. Twenty-four others have been cured/discharged/migrated.

The figure of 341 cases include 63 cases in Maharashtra, which has reported the highest number of COVID-19 cases, including three foreigners.

Kerala has reported 52 cases, including seven foreign nationals.

Delhi has reported 27 positive cases, including a foreigner, while Uttar Pradesh has recorded 25 cases, including a foreigner.

Telangana has reported 21 cases, including 11 foreigners. Rajasthan has reported 24 cases, including two foreigners.

In Haryana, there are 17 cases, which include 14 foreigners.

Karnataka has 20 coronavirus patients. Punjab and Ladakh have 13 cases each. Gujarat has 14 cases while Tamil Nadu has 6 cases, which includes 2 foreigners. Chandigarh has five cases.

Madhya Pradesh, Jammu and Kashmir, and West Bengal reported four cases each. Andhra Pradesh and Uttarakhand have reported three cases each. Odisha and Himachal Pradesh reported 2 cases each.

Puducherry and Chhattisgarh have reported one case each.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India,  the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine. 

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 17,2020

New Delhi, Feb 17: Four death row convicts in the 2012 Nirbhaya gang rape and murder will be hanged on March 3 at 6 am a Delhi court said on Monday.

The Patiala House Court on Monday issued fresh death warrants against four convicts while hearing a petition by the state and Nirbhaya's parents.

Earlier, Delhi High Court on February 5 granted a week's time to the four convicts to avail of all legal remedies available to them and said that the convicts cannot be hanged separately since they were convicted for the same crime.

A Delhi Court had earlier issued a death warrant against the four convicts -- Vinay Sharma, Akshay Thakur, Pawan Gupta, and Mukesh Singh -- on January 7 and they were scheduled to be executed on January 22 at Tihar Jail. Later, the execution was suspended indefinitely by a Delhi court.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.